These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1791315)

  • 1. High TAG-72 serum levels, defined by MoAb B72.3, in premenopausal women with benign breast disease, are associated with type I gross cystic disease.
    Vizoso F; Allende MT; Fernàndez R; Suarez B; Diez MC; Ruibal A
    Int J Biol Markers; 1991; 6(3):197-8. PubMed ID: 1791315
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum MCA, CA 125 and CA 19.9 determination in primary breast cancer.
    Yenisey C; Güner G
    Biochem Soc Trans; 1996 May; 24(2):302S. PubMed ID: 8736960
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between BCM (breast cancer mucin) and CA 549 serum levels cystic breast disease.
    Allende MT; Vizoso F; Roiz MC; Fueyo A; Ruibal A
    Int J Biol Markers; 1990; 5(1):48-9. PubMed ID: 2230352
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucin-like carcinoma-associated antigen (MCA) in breast cancer: clinical experience at the National Cancer Institute of Milan.
    Seregni E; Crippa F; Botti C; Bellotti MG; Bogni A; Pizzichetta M; Bombardieri E
    Int J Biol Markers; 1993; 8(2):124-9. PubMed ID: 8366295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA 15.3 behaviour in cystic breast disease.
    Vizoso F; Allende MT; Fueyo A; Vigal G; García-Morán M; Ruibal A
    Int J Biol Markers; 1989; 4(3):181-2. PubMed ID: 2614087
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibody B72.3 in benign breast lesions.
    Soomro S; Shousha S
    J Clin Pathol; 1990 Dec; 43(12):1026-8. PubMed ID: 2266175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization.
    Del Vecchio S; Camera L; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M
    Int J Rad Appl Instrum B; 1991; 18(1):85-7. PubMed ID: 2010311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum prolactin levels in women with gross cystic breast disease.
    Vizoso F; Allende MT; García-Muñiz JL; Alexandre E; Fueyo A; Ruibal A
    Int J Biol Markers; 1992; 7(4):225-9. PubMed ID: 1491178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The correlation between the serum concentrations of BCM (breast cancer mucin), CA549 and estradiol in women with breast macrocysts].
    Vizoso F; Allende MT; Fueyo A; Ruibal A
    Med Clin (Barc); 1991 Feb; 96(5):198. PubMed ID: 2033998
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum TAG 72 levels in different human carcinomas.
    Correale M; Abbate I; Gargano G; Garrubba M; Muncipinto A; Addabbo L; Colangelo D
    Int J Rad Appl Instrum B; 1991; 18(1):101-3. PubMed ID: 2010293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
    Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
    J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucin-like carcinoma associated antigen (MCA) at presentation with breast cancer.
    Horgan PG; Byrne J; O'Donoghue J; Mooney E; Grimes H; Given HF
    Ir J Med Sci; 1997; 166(4):215-6. PubMed ID: 9394068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential for artifacts in monitoring for the detection of tumor associated antigens (TAG-72 and CEA) in serum from patients undergoing MAb-based diagnostic and therapeutic protocols.
    Ferroni P; Milenic DE; Roselli M; Carrasquillo JA; Raubitschek A; Schlom J; Colcher D
    Int J Biol Markers; 1990; 5(4):166-76. PubMed ID: 2093732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions.
    Pasquinelli R; Barba P; Capasso I; D'Aiuto M; D'Aiuto G; Anzisi AM; De Berardinis P; Guardiola J
    Int J Cancer; 1999 Dec; 84(6):568-72. PubMed ID: 10567900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucin-like carcinoma-associated antigen (MCA) in tissue and serum of patients with breast cancer: clinical applications in prognosis and disease monitoring.
    Molina R; Jo J; Filella X; Zanon G; Grau JJ; Joseph J; Bedini JL; Biete A; Ballesta AM
    Int J Biol Markers; 1993; 8(2):113-23. PubMed ID: 8366294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement C3f serum levels may predict breast cancer risk in women with gross cystic disease of the breast.
    Profumo A; Mangerini R; Rubagotti A; Romano P; Damonte G; Guglielmini P; Facchiano A; Ferri F; Ricci F; Rocco M; Boccardo F
    J Proteomics; 2013 Jun; 85():44-52. PubMed ID: 23639844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?
    Hofman P; Hsi BL; Manie S; Fenichel P; Thyss A; Rossi B
    Breast Cancer Res Treat; 1994; 32(2):213-9. PubMed ID: 7532466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple and sensitive assay for determination of human anti-idiotypic anti-B72.3 antibodies, which is not affected by the presence of tumour-associated glycoprotein 72.
    Reinsberg J; Schmolling J; Ackermann D
    Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):237-44. PubMed ID: 8721411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different immunoreactivity between cyst fluid and serum prolactin in women with cystic breast disease.
    Allende MT; Vizoso F; Mosquera E; Fernández Fernández M; Fernández Llana B; Ruibal A
    Int J Biol Markers; 1991; 6(3):199-200. PubMed ID: 1791316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.